iRGD as a tumor-penetrating peptide for cancer therapyHong Yin, Junnian Zheng, Jǐnjīng Xǔ et al.|Molecular Medicine Reports|2017Cited by 74
Chimeric antigen receptor-modified T Cells inhibit the growth and metastases of established tissue factor-positive tumors in NOG miceQing Zhang, Junnian Zheng, Haiyu Wang et al.|Oncotarget|2016Cited by 24